A Simplified Diagnostic Classification Scheme of Chemotherapy-Induced Peripheral Neuropathy

Dis Markers. 2020 Jan 25:2020:3402108. doi: 10.1155/2020/3402108. eCollection 2020.

Abstract

Background and Objective. The main purpose of this study was to develop a simple automatic diagnostic classification scheme for chemotherapy-induced peripheral neuropathy.

Methods: This was a prospective cohort study that enrolled patients with colorectal or gynecologic cancer post chemotherapy for more than 1 year. The patients underwent laboratory examinations (nerve conduction studies and quantitative sensory tests), and a questionnaire about the quality of life. An unsupervised classification algorithm was used to classify the patients into groups using a small number of variables derived from the laboratory tests. A panel of five neurologists also diagnosed the types of neuropathies according to the laboratory tests. The results by the unsupervised classification algorithm and the neurologists were compared.

Results: The neurologists' diagnoses showed much higher rates of entrapment syndromes (66.1%) and radiculopathies (55.1%) than polyneuropathy (motor/sensory: 33.1%/29.7%). A multivariate analysis showed that the questionnaire was not significantly correlated with the results of quantitative sensory tests (r = 0.27) or the neurologists' diagnoses (r = 0.27) or the neurologists' diagnoses (.

Conclusion: The results of our unsupervised classification algorithm based on three variables of laboratory tests correlated well with the neurologists' diagnoses.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Antineoplastic Agents / adverse effects*
  • Colorectal Neoplasms / drug therapy*
  • Early Diagnosis
  • Female
  • Genital Neoplasms, Female / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Peripheral Nervous System Diseases / chemically induced
  • Peripheral Nervous System Diseases / classification
  • Peripheral Nervous System Diseases / diagnosis*
  • Prospective Studies
  • Quality of Life
  • Severity of Illness Index
  • Unsupervised Machine Learning

Substances

  • Antineoplastic Agents